USPTO trademark

CGTRUACCESS

Under examinationUSPTOWord markClass 9Class 35Class 36Class 42+1

"CGTRUACCESS" is a word mark owned by CG Oncology Inc., filed at the USPTO on April 20, 2026. It is under examination and covers classes 9, 35, 36, 42 and 44.

Official USPTO record
CGTRUACCESS trademark as filed
As filed with the USPTO
Status
Under examination
Since September 11, 2026
Filed
April 20, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99774517
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
5 classes
Ownership

Who owns CGTRUACCESS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services CGTRUACCESS is filed for, grouped by Nice class.

  • Downloadable software featuring online portals for patients, caregivers, healthcare providers, and healthcare provider staff for accessing information, tracking status, exchanging documentation, and managing access to pharmaceutical therapies; downloadable software for administration of patient support programs and for reporting and analytics related to treatment access; downloadable software featuring patient engagement applications, digital companion applications, and communication platforms for use by patients, caregivers, and healthcare providers; downloadable software utilizing artificial intelligence and data analytics for managing patient access, treatment coordination, and reimbursement workflows.

  • Business assistance services in the field of pharmaceuticals, namely, providing patient access support services; administration of patient support programs; providing reimbursement support services, namely, insurance benefits verification, prior authorization assistance, and claims appeals assistance; administration of financial assistance and co-pay support programs for patients; coordination of patient access to pharmaceutical therapies for patients, healthcare providers, and healthcare provider staff; providing business information and assistance to patients and healthcare providers regarding access to pharmaceutical products; operation of patient access hubs for facilitating access to pharmaceutical treatments; insurance eligibility verification services; patient engagement services for business purposes, namely, providing administrative support in the nature of patient education about program eligibility and access processes, and communication and navigation assistance for patients and caregivers; business management services, namely, care coordination in the nature of arranging scheduling and transportation logistics for patients; providing real-time payer access information for business purposes; field reimbursement support services, namely, assisting healthcare providers with insurance reimbursement processes.

  • Financial assistance services, namely, providing financial assistance to patients for the purchase of pharmaceutical products; administration of co-payment assistance, patient assistance, and reimbursement programs

  • Providing temporary use of non-downloadable software for patient support program administration, patient engagement, and communication; providing online portals for patients, caregivers, and healthcare providers for accessing information, exchanging documentation, and managing access to pharmaceutical therapies; providing temporary use of non-downloadable software for data analytics, reporting, and dashboards relating to patient access, reimbursement, and treatment initiation; providing temporary use of non-downloadable software utilizing artificial intelligence for predicting patient access barriers, optimizing workflows, and automating patient support services; providing temporary use of non-downloadable software for integration with electronic health records and healthcare provider systems.

  • Providing healthcare information in the field of pharmaceuticals and treatment access; patient support services, namely, providing healthcare information and patient advocacy services to assist patients in obtaining access to pharmaceutical treatments; providing patient case management services, namely, coordinating healthcare services for patients in connection with access to pharmaceutical therapies; providing patient care navigation and coordination services, namely, coordinating medical and healthcare services; providing personalized patient education and counseling to improve treatment access and adherence; providing patient advocacy services to address barriers to healthcare access, including providing information and assistance relating to logistical and administrative aspects of obtaining medical treatment; all of the foregoing delivered through human-led and digital engagement models.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of non-final action e-mailed
  2. Non-final action e-mailed
  3. Non-final action written
  4. Assigned to examiner
  5. New application office supplied data entered
  6. Application filing receipt mailed
  7. New application entered
FAQ

About CGTRUACCESS

Who owns the trademark "CGTRUACCESS"?

The USPTO trademark "CGTRUACCESS" (application 99774517) is owned by CG Oncology Inc.

What is the status of "CGTRUACCESS"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CGTRUACCESS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019db7f0-1c5c-710f-8929-2a2da1ce358a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019db7f0-1c5c-710f-8929-2a2da1ce358a",
  "object": "trademark",
  "mark_text": "CGTRUACCESS",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99774517",
  "filing_date": "2026-04-20",
  "nice_classes": [
    9,
    35,
    36,
    42,
    44
  ],
  "owners": [
    {
      "name": "CG Oncology Inc.",
      "entity_id": "ent_019eb70f-20f0-736a-805e-dea9ff413d49"
    }
  ]
}